Shaping the Next 175 Years of Human Health

For 175 years, Corning has stood alongside the world’s scientists—helping them push the boundaries of what is possible in medicine. Today, that legacy continues as a new era of discovery unfolds, driven by breakthroughs in cell therapy and precision medicine that promise to transform how we understand, treat, and ultimately prevent disease.

Around the world, cell therapy researchers are advancing treatments once thought impossible. Their work demands more than vision—it requires tools engineered for reliability, scalability, and clinical readiness.

Corning is proud to support this movement. By bringing together deep expertise in materials science and cell biology, we provide the engineered surfaces, scalable platforms, and scientific partnership that help innovators move confidently from early discovery to clinical translation. These technologies, paired with global experience and regulatory know‑how, help transform breakthrough ideas into therapies that change lives.

The future of medicine depends on understanding human biology with greater accuracy than ever before. Corning’s 3D cell culture technologies—including organoids and advanced 3D models—allow scientists to better mimic real human tissues, unlocking insights that were once out of reach.

These tools are reshaping the landscape of precision medicine. By enabling researchers to study disease more accurately and predict treatment responses with greater confidence, Corning’s innovations support the FDA’s vision for New Approach Methods (NAMs) and a future where research is more relevant, ethical, and predictive.